Invention Application
- Patent Title: METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
-
Application No.: US16252424Application Date: 2019-01-18
-
Publication No.: US20190219581A1Publication Date: 2019-07-18
- Inventor: Sarah S. Bacus , Bradley L. Smith
- Applicant: Ventana Medical Systems, Inc. , Cell Signaling Technology, Inc.
- Applicant Address: US AZ Tucson US MA Beverly
- Assignee: Ventana Medical Systems, Inc.,Cell Signaling Technology, Inc.
- Current Assignee: Ventana Medical Systems, Inc.,Cell Signaling Technology, Inc.
- Current Assignee Address: US AZ Tucson US MA Beverly
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/50 ; C07K16/28 ; C07K16/40 ; G01N33/68
Abstract:
This invention provides methods for determining or predicting response to HER2-directed therapy in an individual.
Information query
IPC分类:
